World's Best Scientists 2026 revealed!
Richard B. Kennedy

Richard B. Kennedy

D-Index & Metrics

Immunology

D-Index
51
Citations
8747
World Ranking
4157
National Ranking
1896

Richard B. Kennedy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard B. Kennedy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 149 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard B. Kennedy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard B. Kennedy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1966 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Richard B. Kennedy is affiliated with the Mayo Clinic in the United States. Their research spans several areas within medicine, focusing especially on infectious diseases and immunology. The scientist has produced a substantial body of work, contributing to fields such as medicine, immunology and microbiology, and subfields including infectious diseases, epidemiology, immunology, molecular biology, and health.

The main topics of study covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Vaccines and immunoinformatics approaches
  • Virology and Viral Diseases
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • Immune responses and vaccinations

Among the recent papers associated with Richard B. Kennedy are:

  • SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates, 2020, The Lancet
  • The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity, 2020, Immunological Reviews
  • Prevention of monkeypox with vaccines: a rapid review, 2022, The Lancet Infectious Diseases
  • Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice, 2022, Science Translational Medicine
  • Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations, 2021, Scientific Reports

Richard B. Kennedy frequently collaborates with several researchers, including:

  • Inna G. Ovsyannikova
  • Gregory A. Poland
  • Iana H. Haralambieva
  • Diane E. Grill
  • Huy Quang Quach

The venues where this scientist most often publishes include:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Frontiers in Immunology
  • The Journal of Infectious Diseases

Richard B. Kennedy has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), an award received in 1966.

Best Publications

  • Multiple roles for CD4+ T cells in anti‐tumor immune responses

    Richard Kennedy;Esteban Celis

  • SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.

    Gregory A Poland;Inna G Ovsyannikova;Richard B Kennedy

  • Immunosenescence and human vaccine immune responses.

    Stephen N. Crooke;Inna G. Ovsyannikova;Gregory A. Poland;Richard B. Kennedy

  • Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics.

    Wenan Chen;Beth R. Larrabee;Inna G. Ovsyannikova;Richard B. Kennedy

  • The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.

    Inna G. Ovsyannikova;Iana H. Haralambieva;Stephen N. Crooke;Gregory A. Poland

  • Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade

    Eduardo Davila;Richard Kennedy;Esteban Celis

  • Smallpox and Vaccinia

    Richard B. Kennedy;J. Michael Lane;Donald A. Henderson;Gregory A. Poland

  • Personalized vaccinology: A review

    G.A. Poland;I.G. Ovsyannikova;R.B. Kennedy

  • Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses

    Stefan Avey;Foo Cheung;Damian Fermin

  • Development of vaccines against Zika virus.

    Gregory A Poland;Richard B Kennedy;Inna G Ovsyannikova;Ricardo Palacios

  • Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.

    Stephen N. Crooke;Inna G. Ovsyannikova;Gregory A. Poland;Richard B. Kennedy

  • SARS-CoV-2 Vaccine Development: Current Status

    Gregory A. Poland;Inna G. Ovsyannikova;Stephen N. Crooke;Richard B. Kennedy

  • Systems biology approaches to new vaccine development.

    Ann L Oberg;Richard B Kennedy;Peter Li;Inna G Ovsyannikova

  • Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?

    Gregory A. Poland;Richard B. Kennedy;Inna G. Ovsyannikova

  • The immunology of smallpox vaccines.

    Richard B Kennedy;Inna G Ovsyannikova;Inna G Ovsyannikova;Robert M Jacobson;Gregory A Poland;Gregory A Poland

  • Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

    Gregory A. Poland;Richard B. Kennedy;Richard B. Kennedy;Brett A. McKinney;Brett A. McKinney;Inna G. Ovsyannikova;Inna G. Ovsyannikova

  • Direct Costimulation of Tumor-reactive CTL by Helper T Cells Potentiate Their Proliferation, Survival, and Effector Function

    Robert L. Giuntoli;Jun Lu;Hiroya Kobayashi;Richard Kennedy

  • Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.

    Stephen N. Crooke;Inna G. Ovsyannikova;Richard B. Kennedy;Gregory A. Poland

  • Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

    Gregory A. Poland;Inna G. Ovsyannikova;Richard B. Kennedy;Iana H. Haralambieva

  • Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.

    Colin Pawlowski;Arjun Puranik;Hari Bandi;A. J. Venkatakrishnan

Frequent Co-Authors

Ann L. Oberg
Ann L. Oberg Mayo Clinic
V. Shane Pankratz
V. Shane Pankratz University of New Mexico
Daniel J. Schaid
Daniel J. Schaid Mayo Clinic
Esteban Celis
Esteban Celis Augusta University
Jun Lu
Jun Lu Zhejiang University
Andrew D. Badley
Andrew D. Badley Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, there are numerous complementary online degree options in related healthcare fields, especially nursing and advanced practice roles. Exploring dnp salary transparency can provide valuable insight into earning potential across different regions, helping students strategically plan their careers.

Many registered nurses (RNs) aim to advance to nurse practitioner roles through accelerated pathways. Programs highlighted in accelerated rn to np programs allow for a faster transition, which is ideal for those eager to apply immunology expertise in clinical settings.

For individuals without prior nursing experience interested in pivoting into healthcare, online rn programs for non nurses offer flexible learning options designed to build foundational knowledge efficiently.

Additionally, nurses who have already specialized as family nurse practitioners (FNPs) may consider obtaining acute care certification for fnp. This certification enables practitioners to work in more intensive care environments, aligning well with immunology-driven healthcare advancements.

Best Scientists Citing Richard B. Kennedy

Trending Scientists

Recently Published Articles